Eli Lilly shares rise over 3% pre-market as experimental injection shows 23% weight reduction in study.

Thursday, Dec 11, 2025 6:52 am ET1min read

Eli Lilly shares rise over 3% pre-market as experimental injection shows 23% weight reduction in study.

Comments



Add a public comment...
No comments

No comments yet